256
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Curative effect of remifentanil on labor analgesia in newborns

, , , &
Pages 1913-1918 | Received 25 Jul 2018, Accepted 05 Oct 2018, Published online: 08 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Meng Cai, Jie Liu, Xiao-Feng Lei, Yun-Long Li & Jin Yu. (2023) Remifentanil at a Relatively Elevated Dose in Active Phase is Safe and More Suitable Than Fixed Lower Dose for Intravenous Labor Analgesia. Journal of Pain Research 16, pages 2543-2552.
Read now

Articles from other publishers (4)

E. Guasch Arévalo & N. Brogly. (2023) Intravenous remifentanil for labour analgesia: is it effective, safe, and feasible?. Revista Española de Anestesiología y Reanimación (English Edition) 70:9, pages 487-490.
Crossref
E. Guasch Arévalo & N. Brogly. (2023) Remifentanilo intravenoso para analgesia en el dolor del trabajo de parto: ¿es eficaz, seguro y factible?. Revista Española de Anestesiología y Reanimación 70:9, pages 487-490.
Crossref
Xiuzhen Lei, Yang Yu, Mei Li, Peng Fang, Shuyuan Gan, Yongxing Yao, Yanfeng Zhou & Xianhui Kang. (2022) The efficacy and safety of remifentanil patient-controlled versus epidural analgesia in labor: A meta-analysis and systematic review. PLOS ONE 17:12, pages e0275716.
Crossref
P Štourač, J Bláha, M Kosinová, J Mannová, P Nosková, H Harazim & D Seidlová. (2020) Year 2020 in review - Anaesthesiology in obstetrics. Anesteziologie a intenzivní medicína 31:6, pages 299-304.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.